Cognitive symptoms are a core feature of schizophrenia and are related to an unfavorable disease outcome. So far, there are no satisfactory pharmacological approaches to address cognitive symptoms. For some time now, aerobic exercise has been demonstrated in various trials to be a promising candidate for this indication. The aim of this brief qualitative review was to present the most recent meta-analyses regarding the capacity of exercise to improve cognition in schizophrenia patients. Additionally, we give a short overview of the effects in other conditions, like healthy subjects and patients with major depression. We conducted a focused literature search using the PubMed database, concentrating on meta-analyses which are based on a systematic search. The most recent meta-analysis investigating the efficacy of aerobic exercise on cognitive impairments in schizophrenia patients provides evidence that exercise has positive effects on cognitive functioning in this population. However, the effect seems not to be specific; there were positive findings regarding healthy subjects and patients with depressive disorders as well, even if they were less consistent. As most available trials have a small to modest sample size and have no consensus with regard to the intervention regime, nor to the assessment of cognition, the findings are difficult to generalize. In the future, standardized clinical trials focusing on the long-term effects of exercise are needed to evaluate whether the improvements in cognition are sustainable.
Introduction
Cognitive symptoms are a core symptom of schizophrenia that can already be measured prior to the initiation of the first antipsychotic treatment. 1 Cognitive symptoms are related to unfavorable disease outcomes, long-lasting chronicity, and impairments in social and occupational functioning. 2 The management of the great variety of cognitive impairments covering all aspects of cognition including impairments in declarative memory, the ability to shift strategies, working memory, and processing speed 3 is one of the greatest challenges in clinical practice and in schizophrenia research. For a long period, there was the hope that antipsychotic treatment, especially with second-generation antipsychotics, would be effective in ameliorating at least some cognitive impairments. Despite their very high efficacy for positive symptoms, 4 older and recent meta-analyses could not convincingly show their efficacy for cognitive symptoms. [5] [6] [7] It has been established that cognitive symptoms can improve as a consequence of reduced positive symptoms (secondary effect of an antipsy -chotic treatment), but whether antipsychotics can directly improve impaired cognition remains elusive. Moreover, a blockade of D2 receptors and especially a treatment with anticholinergics to manage antipsychotic-induced motor side effects can even pronounce cognitive symptoms. Psychosocial treatments like cognitive training and cognitive remediation were shown to be effective in the management of cognitive impairments in schizophrenia 8 and such programs should be offered to schizophrenia patients with cognitive impairments.
However, there is an urgent need to develop new strategies for this indication. At best, such strategies would be grounded in biological evidence derived from animal models. The potential of aerobic exercise to induce plasticity, and thus to improve cognition, was shown many years ago. 9 Various factors to explain this effect, including neurogenesis, the increase in growth factors, or the normalization of an impaired excitation/inhibition balance have been discussed to be mechanistically involved in this process. 10 Thus, the questions arose as to whether aerobic exercise can also improve cognition via increased neuroplasticity in patients with schizophrenia or other psychotic disorders. Exercise treatment has been an integral part of the broad array of psychosocial treatments in psychiatry for a long time, but the perspective of improving neural plasticity in cognition through exercise is still a rather new one. The landmark trial by Pajonk et al 11 showed in a small sample that 12 weeks of aerobic exercise could not only improve cognition in schizophrenia patients, but also induce structural plasticity in the hippocampus. Since then, some studies were able to confirm this finding, but negative findings were also observed. 12 Moreover, a magnitude of research of the last years 13 confirmed a beneficial effect of exercise not only in schizophrenia patients, but also in healthy subjects and in patients with neurological disorders. Moreover, a substantial body of evidence indicates that exercise, but also physical activity in general, is linked to academic performance and later cognitive performance in adolescents. 14, 15 The aim of this brief qualitative review was to show the most recent meta-analyses regarding the capacity of exercise to improve cognition in humans focusing on schizophrenia patients. When discussing interventions like exercise that are on the one hand supported by strong biological evidence, but are on the other hand very likely to induce broad clinical effects rather than specific effects, it is important to ask questions regarding specificity. Therefore, we decided to give a short overview of the effects of exercise not only in other conditions like major depression, but also in healthy subjects. However, the literature presented here represents only a small excerpt from the available evidence.
Methods
For this brief qualitative review, we conducted a focused literature search using the PubMed database. On March 26, 2019, we searched the database using the search terms "exercise" OR "physical activity" AND "cognition" using the meta-analyses filter. We were able to identify 133 meta-analyses. These publications were screened at the abstract level by IM and the selected references were discussed between IM and AH. We decided to focus on meta-analyses as this approach allows for a literature selection based on systematically searched literature (meta-analytical evidence). Our aim was to provide an overview of the topic; a separate meta-analysis was not carried out for this purpose. Thus, our review presented here is not the result of a full systematic search, but is based on sources of evidence that were systematically searched. To put the results in a schizophrenia perspective, we decided not only to include meta-analyses focusing on schizophrenia patients, but also those focusing on major depressive disorder (MDD), bipolar disorder (BD), and healthy subjects (including children, adolescents, and older adults). The results of the selected meta-analyses are presented in Table I and include the most matching published meta-analyses regarding exercise as intervention to improve cognition in patients with MDD and BP, and in and healthy subjects. The following text focuses on schizophrenia patients.
Results
From the identified 133 publications, we decided to add 15 studies to Table I [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] to give the reader a focused overview regarding this topic. Below we present the findings by the latest meta-analysis investing the efficacy of aerobic exercise on cognitive impairments in schizophrenia patients 16 in more detail. Firth et al evaluated ten trials with cognitive outcome More endeavors should be made to increase physical activity in the everyday life of schizophrenia patients
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data for 385 patients with schizophrenia, among them seven randomized controlled studies. In their meta-analysis they could show, that exercise significantly improved global cognition (g=0.33, 95% CI =0.13-0.53, P=.001) with no statistical heterogeneity (I 2 = 0%), providing evidence that exercise has positive effects on cognitive functioning among people with schizophrenia. When only the RCTs were considered, the effect size was even g=0.43 (P<.001). Using meta-regression analyses the authors concluded, that greater amounts of exercise were associated with larger improvements in global cognition (β=.005, P=.065). Moreover, interventions which were supervised by physical activity professionals were also more effective (g=0.47, P<.001). Regarding the subdomains of cognition, exercise significantly improved working memory (g=0.39, P=.024), social cognition (g=0.71, P=.002), and attention/vigilance (g=0.66, P=.005). As social cognitive impairments are negatively associated with employment and independent living 31, 32 and attention/vigilance is a strong predictor of functional recovery particularly after a first episode of schizophrenia, 33 both domains are important variables regarding the patients' outcome in real-world functioning. 34 As for processing speed, verbal memory, visual memory and reasoning, and problem solving, the authors found no significant effects. Firth et al concluded that exercise is similarly effective in improving cognition in schizophrenia to cognitive remediation therapy, which had an average effect size of g=0.45 (95% CI=0.31-0.59) in randomized trials. 16, 35 They therefore suggest combining exercise with cognitively demanding tasks to confer maximal benefits for cognition in schizophrenia patients in the future, as this has already been done in some studies with preliminary positive results. 36 Please see Table I for the description of the other selected meta-analyses.
Conclusions
Aerobic exercise has shown the potential to improve cognitive impairments in schizophrenia patients, though this effect does not seem to be specific, or rather restricted, to this condition. When discussing the effects of exercise on cognition, it is important to differentiate two aspects. First, the effects of physical exercise early in life or the effects of being active in older age on cognitive functioning. The importance of exercise/physical activity has been confirmed by epidemiological studies. 37 Second, the effects of exercise in terms of direct treatment in schizophrenia patients or other psychiatric or neurological conditions. Such evidence came from controlled or uncontrolled clinical trials that applied specific training (eg, cycling, yoga) for a specific time period and measured cognitive function prior to and after the treatment. These trials are the basis for the available meta-analyses and as shown in the most recent one by Firth et al, 16 exercise can improve global and specific cognitive functions in schizophrenia patients (see results, and Table I for details). The effects for depressive disorders 18 were less consistent, suggesting a more specific effect of exercise in schizophrenia. Taking the more pronounced cognitive impairments in schizophrenia, compared with depression, into consideration, one could speculate that a more severe presentation of symptoms is more likely to respond to a given intervention.
However, the reader should bear in mind that no systematic searches in different databaseses were carried out, but that a focused literature search based on systematically searched literature in meta-analyses was used for this article. In addition, despite the promising results from the meta-analysis shown here, most available trials are from a small to modest sample size, no multicenter trial is available yet, and neither the applied interventions nor the used measures to access cognition are comparable. Thus, the question of the generalizability of these findings cannot be answered. Moreover, long follow-up periods are needed, as are studies evaluating whether the improvement in cognition is sustained after the termination of the clinical trial. Without these trials, it remains unclear if exercise treatment has a long-lasting effect on cognition in schizophrenia or whether the effect is restricted to the setting of a clinical trial.
When discussing the effects of exercise on cognition in schizophrenia, the aspect of exercise as an environmental factor needs to be considered. As detailed above, being active in general improves cognition and seems to be protective regarding cognitive decline. Schizophrenia patients suffer from a sedentary lifestyle and it has been consistently shown that patients are less active in general compared with healthy controls. 38 The reasons for this include the effects of negative symptoms, the effects of sedation, and the lack of social stimuli for these patients. Thus, for future research two strategies should be followed. First, we do need better clinical trials in this area specifically focusing on the long-term outcomes of exercise treatments. For such trials, a consensus of the intervention scheme and the outcome measures is needed. For the latter, consensus approaches from other fields of schizophrenia research 39 
should be
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applied. Second, exercise and physical activity programs must be implemented in the clinical routine of in-and outpatient settings and societal programs to involve schizophrenia patients in eg, sport or fitness clubs must be set up. Such approaches will not only improve cognitive functioning in schizophrenia patients, but also help to reduce the high cardiovascular mortality and foster the integration of those persons. However, we are aware that the second approach is difficult and that is not very likely that such programs will be implemented. On the other hand, we believe that exercise in schizophrenia patients must not be restricted to clinical trials. In summary, exercise has a positive impact on cognitive functions in schizophrenia, but more research is needed as detailed above. In particular, more endeavors should be made to increase physical activity in the everyday life of schizophrenia patients. n Disclosure/Acknowledgements: I. Maurus, A. Röh, and B. Malchow declare no conflicts of interest. P. Falkai has been an honorary speaker for AstraZeneca, Bristol Myers Squibb, Lilly, Essex, GE Healthcare, GlaxoSmithKline, Janssen Cilag, Lundbeck, Otsuka, Pfizer, Servier, and Takeda, and has been a member of the advisory boards of Janssen-Cilag, AstraZeneca, Lilly, and Lundbeck. A. Schmitt was honorary speaker for TAD Pharma and Roche and a member of Roche advisory boards. A. Hasan has been invited to scientific meetings by Lundbeck, Janssen-Cilag, and Pfizer, and he received a paid speakership from Desitin, Otsuka and Lundbeck. He was member of an advisory board of Roche.
